Your Article Summary
Anti-TNFalpha blockers, autoantibodies and autoimmune diseases
Joint, Bone, Spine, 06/25/09
Caramaschi P et al. - While the development of antinuclear and, less frequently, of anti-DNA antibodies is a common finding, the onset of autoimmune diseases during anti-TNFalpha blocker treatment is a rare event, which needs to be promptly recognized in order to plan the appropriate management. Moreover the specific autoantibodies associated with rheumatoid arthritis are considered before and after biotherapy.
Related Articles
Cytotoxic T lymphocyte antigen-4 Ala17 polymorphism is a genetic marker of autoimmune adrenal insufficiency: Italian association study and meta-analysis of European studies
European Journal of Endocrinology, 11/05/09
Relevance Score: 69%
Cross-regulation of Signaling Pathways by Interferon-[gamma]: Implications for Immune Responses and Autoimmune Diseases
Immunity, 10/28/09
Relevance Score: 69%
iTRAQ-based proteomic identification of leucine rich alpha 2 glycoprotein (LRG) as a novel inflammatory biomarker in autoimmune diseases
Annals of Rheumatic Diseases, 11/09/09
Relevance Score: 68%
Familial clustering, genetic roots and insights into the pathogenesis of autoimmune diseases
Zeitschrift für Rheumatologie, 10/29/09
Relevance Score: 68%
Autoimmune pancreatitis: A mimic of pancreatic cancer
Cleveland Clinic Journal of Medicine, 10/16/09
Relevance Score: 68%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of biological drug adalimumab on tumour necrosis factor-alpha-converting enzyme activation
Immunology & Cell Biology, 12/08/09
Severe atopic dermatitis treated with everolimus
Journal of Dermatological Treatment , 12/07/09
Benefits of budesonide or nedocromil for mild to moderate asthma in children were not sustained after discontinuation
Evidence-Based Medicine, 12/07/09
Today in Rheumatic/Autoimmune...keeping you current
Receive free subspecialty "5-minute updates" via email
Crystal-induced neutrophil activation
Immunology & Cell Biology, 12/08/09
Inhibition of clonal expansion by Foxp3 expression as a mechanism of controlled T-cell responses and autoimmune disease
European Journal of Immunology, 12/07/09
Th1, Th17, and Th9 Effector Cells Induce Experimental Autoimmune Encephalomyelitis with Different Pathological Phenotypes
Journal of Immunology, 12/07/09

See Latest Articles